Clinical Trials Browser

Phase 2 × Angiogenesis Inhibitors × 1 year × Clear all

NCT03890952 2025-07-24

Translational Study of Nivolumab in Combination With Bevacizumab for Recurrent Glioblastoma

Phase 2 Completed

Brain Neoplasms